These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15920985)

  • 1. Dosimetry parameters of BARC OcuProsta I-125 seed source.
    Sharma SD; Basu M; Shanta A; Selvam TP; Tripathi UB; Bhatt BC
    Australas Phys Eng Sci Med; 2005 Mar; 28(1):14-20. PubMed ID: 15920985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
    Medich DC; Munro JJ
    Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer gel dosimetry for the TG-43 dosimetric characterization of a new 125I interstitial brachytherapy seed.
    Papagiannis P; Pantelis E; Georgiou E; Karaiskos P; Angelopoulos A; Sakelliou L; Stiliaris S; Baltas D; Seimenis I
    Phys Med Biol; 2006 Apr; 51(8):2101-11. PubMed ID: 16585848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
    Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric characterization of GMS BT-125-1
    Zhao N; Yang R; Ren L; Fan Y; Li J; Zhang J
    J Appl Clin Med Phys; 2017 Nov; 18(6):49-57. PubMed ID: 28905514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric characteristic of a new 125I brachytherapy source.
    Sadeghi M; Khanmohammadi Z
    Radiat Prot Dosimetry; 2011 Nov; 147(3):451-6. PubMed ID: 21233096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo dosimetry of the selectSeed 125I interstitial brachytherapy seed.
    Karaiskos P; Papagiannis P; Sakelliou L; Anagnostopoulos G; Baltas D
    Med Phys; 2001 Aug; 28(8):1753-60. PubMed ID: 11548946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O; Williamson JF; Todor D
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE 125I brachytherapy source.
    Meigooni AS; Hayes JL; Zhang H; Sowards K
    Med Phys; 2002 Sep; 29(9):2152-8. PubMed ID: 12349937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A photon spectrometric dose-rate constant determination for the Advantage Pd-103 brachytherapy source.
    Chen ZJ; Bongiorni P; Nath R
    Med Phys; 2010 Feb; 37(2):672-4. PubMed ID: 20229876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
    Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
    J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-field dosimetry of 125I sources for interstitial brachytherapy implants measured using thermoluminescent sheets.
    Iwata K; Yue NJ; Nath R
    Med Phys; 2004 Dec; 31(12):3406-16. PubMed ID: 15651623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermoluminescent dosimetry of the SourceTech Medical model STM1251 125I seed.
    Chiu-Tsao ST; Duckworth TL; Hsiung CY; Li Z; Williamson J; Patel NS; Harrison LB
    Med Phys; 2003 Jul; 30(7):1732-5. PubMed ID: 12906190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.
    Meigooni AS; Dini SA; Awan SB; Dou K; Koona RA
    Appl Radiat Isot; 2006 Aug; 64(8):881-7. PubMed ID: 16713277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom.
    Chiu-Tsao ST; Medich D; Munro J
    Med Phys; 2008 Aug; 35(8):3787-99. PubMed ID: 18777938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric characteristics of the Pharma Seed model BT-125-I source.
    Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS
    Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermoluminescent dosimetry of the selectseed 125I interstitial brachytherapy seed.
    Anagnostopoulos G; Baltas D; Karaiskos P; Sandilos P; Papagiannis P; Sakelliou L
    Med Phys; 2002 May; 29(5):709-16. PubMed ID: 12033566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric properties of the new 125I BrachySeed model LS-1 source.
    Chan GH; Prestwich WV
    Med Phys; 2002 Feb; 29(2):190-200. PubMed ID: 11865990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.